162 related articles for article (PubMed ID: 35638041)
1. Continuously protracted infusion of cisatracurium besilate in patients with ARDS.
Yuan Z; Pan L; Wang Y; Wang W
Ann Med Surg (Lond); 2022 May; 77():103718. PubMed ID: 35638041
[TBL] [Abstract][Full Text] [Related]
2. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.
Needham CJ; Brindley PG
Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702
[TBL] [Abstract][Full Text] [Related]
3. Sedation and neuromuscular blocking agents in acute respiratory distress syndrome.
Bourenne J; Hraiech S; Roch A; Gainnier M; Papazian L; Forel JM
Ann Transl Med; 2017 Jul; 5(14):291. PubMed ID: 28828366
[TBL] [Abstract][Full Text] [Related]
4. Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials.
Tarazan N; Alshehri M; Sharif S; Al Duhailib Z; Møller MH; Belley-Cote E; Alshahrani M; Centofanti J; McIntyre L; Baw B; Meade M; Alhazzani W;
Intensive Care Med Exp; 2020 Oct; 8(1):61. PubMed ID: 33095344
[TBL] [Abstract][Full Text] [Related]
5. The effect of neuromuscular blocking agents uses in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
Lyu T; Lee YS; Dhanvijay S; Freebairn R
Minerva Anestesiol; 2021 Mar; 87(3):341-350. PubMed ID: 33300324
[TBL] [Abstract][Full Text] [Related]
6. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
Mefford B; Donaldson JC; Bissell BD
Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121
[No Abstract] [Full Text] [Related]
7. Association between tidal volume size, duration of ventilation, and sedation needs in patients without acute respiratory distress syndrome: an individual patient data meta-analysis.
Serpa Neto A; Simonis FD; Barbas CS; Biehl M; Determann RM; Elmer J; Friedman G; Gajic O; Goldstein JN; Horn J; Juffermans NP; Linko R; de Oliveira RP; Sundar S; Talmor D; Wolthuis EK; de Abreu MG; Pelosi P; Schultz MJ
Intensive Care Med; 2014 Jul; 40(7):950-7. PubMed ID: 24811940
[TBL] [Abstract][Full Text] [Related]
8. Prolonged weakness after cisatracurium infusion: a case report.
Davis NA; Rodgers JE; Gonzalez ER; Fowler AA
Crit Care Med; 1998 Jul; 26(7):1290-2. PubMed ID: 9671384
[TBL] [Abstract][Full Text] [Related]
9. Neuromuscular blockers in early acute respiratory distress syndrome.
Papazian L; Forel JM; Gacouin A; Penot-Ragon C; Perrin G; Loundou A; Jaber S; Arnal JM; Perez D; Seghboyan JM; Constantin JM; Courant P; Lefrant JY; Guérin C; Prat G; Morange S; Roch A;
N Engl J Med; 2010 Sep; 363(12):1107-16. PubMed ID: 20843245
[TBL] [Abstract][Full Text] [Related]
10. Application of Neuromuscular Blockers in Patients with ARDS in ICU: A Retrospective Study Based on the MIMIC-III Database.
Pan X; Liu J; Zhang S; Huang S; Chen L; Shen X; Chen D
J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902664
[TBL] [Abstract][Full Text] [Related]
11. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults.
Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD
Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347
[TBL] [Abstract][Full Text] [Related]
12. An Observational Study of the Efficacy of Cisatracurium Compared with Vecuronium in Patients with or at Risk for Acute Respiratory Distress Syndrome.
Sottile PD; Kiser TH; Burnham EL; Ho PM; Allen RR; Vandivier RW; Moss M;
Am J Respir Crit Care Med; 2018 Apr; 197(7):897-904. PubMed ID: 29241014
[TBL] [Abstract][Full Text] [Related]
13. Neuromuscular blockade in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
Ho ATN; Patolia S; Guervilly C
J Intensive Care; 2020; 8():12. PubMed ID: 32015880
[TBL] [Abstract][Full Text] [Related]
14. Management of Neuromuscular Blocking Agents in Critically Ill Patients with Lung Diseases.
Iavarone IG; Al-Husinat L; Vélez-Páez JL; Robba C; Silva PL; Rocco PRM; Battaglini D
J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398494
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Cisatracurium Continuous Infusion Dose in Acute Respiratory Distress Syndrome.
Merkel A; Massey K; Bellamy C; Miano T; Fuchs B; Candeloro C
J Pharm Pract; 2021 Aug; 34(4):600-605. PubMed ID: 31736402
[TBL] [Abstract][Full Text] [Related]
16. How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study.
Hraiech S; Forel JM; Guervilly C; Rambaud R; Lehingue S; Adda M; Sylla P; Valera S; Carvelli J; Gainnier M; Papazian L; Bourenne J
Ann Intensive Care; 2017 Dec; 7(1):79. PubMed ID: 28770545
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Cisatracurium Compared to Vecuronium for Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
Vallabh P; Ha M; Ahern K
J Intensive Care Med; 2023 Feb; 38(2):188-195. PubMed ID: 35821572
[TBL] [Abstract][Full Text] [Related]
18. Early neuromuscular blocking agents for adults with acute respiratory distress syndrome: a systematic review, meta-analysis and meta-regression.
Shao S; Kang H; Tong Z
BMJ Open; 2020 Nov; 10(11):e037737. PubMed ID: 33444180
[TBL] [Abstract][Full Text] [Related]
19. Clinical assessment and train-of-four measurements in critically ill patients treated with recommended doses of cisatracurium or atracurium for neuromuscular blockade: a prospective descriptive study.
Bouju P; Tadié JM; Barbarot N; Letheulle J; Uhel F; Fillatre P; Grillet G; Goepp A; Le Tulzo Y; Gacouin A
Ann Intensive Care; 2017 Dec; 7(1):10. PubMed ID: 28102521
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.
Bellani G; Laffey JG; Pham T; Fan E; Brochard L; Esteban A; Gattinoni L; van Haren F; Larsson A; McAuley DF; Ranieri M; Rubenfeld G; Thompson BT; Wrigge H; Slutsky AS; Pesenti A; ;
JAMA; 2016 Feb; 315(8):788-800. PubMed ID: 26903337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
